Incidence of drug-induced hepatic injuries: a French population-based study - PubMed (original) (raw)
Incidence of drug-induced hepatic injuries: a French population-based study
Catherine Sgro et al. Hepatology. 2002 Aug.
Abstract
The incidence of hepatic adverse drug reactions (ADRs) remains unknown in the general population. The goal of this population-based study was to assess the incidence and seriousness of hepatic ADRs. All new cases of symptomatic drug-induced hepatic injuries were collected by 139 trained physicians (general practitioners [GPs] and specialists) between November 1997 and November 2000 in an area containing 81,301 inhabitants who could not go elsewhere for medical care. Over 3 years, 34 cases of hepatic ADRs were collected, 82% of them in outpatients. Global crude annual incidence rate was 13.9 +/- 2.4 per 100,000 inhabitants; corresponding standardized annual global rate was 8.1 +/- 1.5. There was no difference between urban and rural areas. Standardized incidence female/male ratio was 0.86 (0.26-2.90) until 49 years of age and 2.62 (1.00-6.92) after this age. Diagnosis was carried out by GPs in half of the cases. The outcome was recovery for 32 patients and death for 2. The main drugs implicated were anti-infectious, psychotropic, hypolipidemic agents, and nonsteroidal anti-inflammatory drugs (NSAIDs). Our results suggest that the number of hepatic ADRs in the French population would be 16 times greater than the number noted by spontaneous reporting to French regulatory authorities. In conclusion, the incidence and seriousness of drug-induced hepatitis are largely underestimated in the general population. These results may be useful for further evaluation of drug-induced hepatotoxicity.
Comment in
- Drug-induced hepatic injury in Sweden.
Olsson R, Brunlöf G, Johansson ML, Persson M. Olsson R, et al. Hepatology. 2003 Aug;38(2):531-2. doi: 10.1053/jhep.2003.50284. Hepatology. 2003. PMID: 12883499 No abstract available.
Similar articles
- Hepatic adverse effects: another example of undernotification.
[No authors listed] [No authors listed] Prescrire Int. 2003 Feb;12(63):19. Prescrire Int. 2003. PMID: 12602390 No abstract available. - Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
Lapeyre-Mestre M, de Castro AM, Bareille MP, Del Pozo JG, Requejo AA, Arias LM, Montastruc JL, Carvajal A. Lapeyre-Mestre M, et al. Fundam Clin Pharmacol. 2006 Aug;20(4):391-5. doi: 10.1111/j.1472-8206.2006.00416.x. Fundam Clin Pharmacol. 2006. PMID: 16867024 - [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D. Dumortier G, et al. Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Encephale. 2002. PMID: 12506267 Review. French. - Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
Walker AM. Walker AM. Arthritis Rheum. 1997 Feb;40(2):201-8. doi: 10.1002/art.1780400204. Arthritis Rheum. 1997. PMID: 9041931 Review. - A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom.
García Rodríguez LA, Ruigómez A, Jick H. García Rodríguez LA, et al. Pharmacotherapy. 1997 Jul-Aug;17(4):721-8. Pharmacotherapy. 1997. PMID: 9250549
Cited by
- Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs.
Chen VL, Rockey DC, Bjornsson ES, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network Investigators. Chen VL, et al. Drug Saf. 2024 Sep 24. doi: 10.1007/s40264-024-01486-6. Online ahead of print. Drug Saf. 2024. PMID: 39317916 - Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions.
Mak LY, Liu K, Chirapongsathorn S, Yew KC, Tamaki N, Rajaram RB, Panlilio MT, Lui R, Lee HW, Lai JC, Kulkarni AV, Premkumar M, Lesmana CRA, Hsu YC, Huang DQ. Mak LY, et al. Nat Rev Gastroenterol Hepatol. 2024 Aug 15. doi: 10.1038/s41575-024-00967-4. Online ahead of print. Nat Rev Gastroenterol Hepatol. 2024. PMID: 39147893 Review. - [Liver diseases in the intensive care unit].
Roedl K, Fuhrmann V. Roedl K, et al. Med Klin Intensivmed Notfmed. 2024 Sep;119(6):449-457. doi: 10.1007/s00063-024-01157-5. Epub 2024 Jun 27. Med Klin Intensivmed Notfmed. 2024. PMID: 38937335 Review. German. - Age-related differences in drug-induced liver injury: a retrospective single-center study from a large liver disease specialty hospital in China, 2002-2022.
Yu S, Li J, He T, Zheng H, Wang S, Sun Y, Wang L, Jing J, Wang R. Yu S, et al. Hepatol Int. 2024 Aug;18(4):1202-1213. doi: 10.1007/s12072-024-10679-1. Epub 2024 Jun 19. Hepatol Int. 2024. PMID: 38898191 Free PMC article. - The Association Between Antidepressant Use and Drug-Induced Liver Injury: A Nationwide, Population-Based Case-Control Study in Taiwan.
Huang CY, You YS, Lai JM, Lin CL, Hsu HY, Hsieh YW. Huang CY, et al. Drugs Real World Outcomes. 2024 Sep;11(3):513-520. doi: 10.1007/s40801-024-00419-0. Epub 2024 Jun 5. Drugs Real World Outcomes. 2024. PMID: 38837010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical